argenx Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024 01:00 ET
|
argenx SE
$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in...
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
May 08, 2024 21:15 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
May 08, 2024 20:00 ET
|
Organovo, Inc.
ONVO announced the pricing of a public offering consisting of 6,562,500 shares of common stock (or pre-funded warrants in lieu thereof).
Global Water Resources Reports First Quarter 2024 Results
May 08, 2024 18:45 ET
|
Global Water Resources, Inc.
PHOENIX, May 08, 2024 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the first quarter ended March 31, 2024. All...
LogicMark, Inc. to Present at Aegis Capital Corp. Virtual Conference on May 9, 2024
May 08, 2024 17:53 ET
|
LogicMark, Inc.
LOUISVILLE, Ky., May 08, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems (PERS), health communications devices, and technology for the...
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
May 08, 2024 17:47 ET
|
Acumen Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic...
Middlesex Water Announces First Quarter 2024 Results
May 08, 2024 17:45 ET
|
Middlesex Water Company
Middlesex Water Company announces First Quarter 2024 Financial Results
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
May 08, 2024 17:35 ET
|
Plus Therapeutics Inc.
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
Dime Hires Veteran Long Island Banker
May 08, 2024 17:30 ET
|
Dime Community Bancshares, Inc.
HAUPPAUGE, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) announced today...
Lamar Advertising to appear at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
May 08, 2024 17:25 ET
|
Lamar Advertising Company
BATON ROUGE, La., May 08, 2024 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) today announced that Sean Reilly, CEO of Lamar Advertising Company, is scheduled to participate in a...